Status:
COMPLETED
A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance.
Lead Sponsor:
Hacettepe University
Conditions:
Cystic Fibrosis-related Diabetes
Diabetes Mellitus
Eligibility:
All Genders
10-18 years
Brief Summary
Cystic fibrosis (CF) is autosomal recessive, genetic disorder cause of cystic fibrosis transmembrane regulatory (CFTR) gene mutation. CF often is observed in caucasian population. CFTR protein in cell...
Detailed Description
The study aimed that comparison of clinical parameters in children with and without abnormal glucose tolerance in Cystic fibrosis.
Eligibility Criteria
Inclusion
- Cystic fibrosis with impaired glucose tolerance or cystic fibrosis-related diabetes for Abnormal glucose tolerance group
- Cooperation for tests
- Indıviduals without an orthopedic or neurological problem and serious cardiac problems that effecting tests,
- To volunteer for the study.
- For the control group
- Cystic fibrosis with normal glucose tolerance
- Cooperation for tests
- Indıviduals without an orthopedic or neurological problem and serious cardiac problems that effecting tests,
- To volunteer for the study.
Exclusion
- Patients having following disease
- Acute pulmonary exacerbation
- Acute or chronic respiratory failure
- FEV₁ lower than %40
- Cooperation problems,
- Bronchopulmonary aspergillus and using steroid.
Key Trial Info
Start Date :
September 13 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 11 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04503408
Start Date
September 13 2019
End Date
March 11 2020
Last Update
August 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Elif Kocaaga
Ankara, Turkey (Türkiye), 06230